{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:30:54Z","timestamp":1792791054658,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"publisher","award":["MU-Phra-20-9"],"award-info":[{"award-number":["MU-Phra-20-9"]}],"id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108624","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:01:09Z","timestamp":1748001669000},"page":"108624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Tipranavir analogs as antiviral agents: Design, synthesis, in vitro, and in silico study of new SARS-CoV-2 main protease inhibitors"],"prefix":"10.1016","volume":"163","author":[{"given":"Selwan M.","family":"El-Sayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina I.A.","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada S.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H.E.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahenda M.","family":"El-Messery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed R.","family":"El-Sheakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108624_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020739","article-title":"After the hurricane: anti-COVID-19 drugs development, molecular mechanisms of action and future perspectives","volume":"25","author":"Khalifa","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108624_bb0010","doi-asserted-by":"crossref","first-page":"13550","DOI":"10.1021\/acs.jmedchem.3c02469","article-title":"A second-generation Oral SARS-CoV-2 Main protease inhibitor clinical candidate for the treatment of COVID-19","volume":"67","author":"Allerton","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108624_bb0015","series-title":"WHO Coronavirus (COVID-19) Dashboard., in","author":"World Health Organisation","year":"2024"},{"key":"10.1016\/j.bioorg.2025.108624_bb0020","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","article-title":"Long COVID science, research and policy","volume":"30","author":"Al-Aly","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2025.108624_bb0025","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","article-title":"Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) condition or long COVID: a Meta-analysis and systematic review","volume":"226","author":"Chen","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bioorg.2025.108624_bb0030","series-title":"Progress in Molecular Biology and Translational Science","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.pmbts.2023.09.002","article-title":"Chapter two - epidemiology of COVID-19","author":"Zaidi","year":"2024"},{"key":"10.1016\/j.bioorg.2025.108624_bb0035","unstructured":"COVID-19 Epidemiological Update \u2013 12 April 2024., in, https:\/\/www.who.int\/publications\/m\/item\/covid-19-epidemiological-update-edition-166, Accessed on 12 May 2024."},{"key":"10.1016\/j.bioorg.2025.108624_bb0040","series-title":"A Mini-Review on the Common Antiviral Drug Targets of Coronavirus, in: Microorganisms","author":"Wang","year":"2024"},{"key":"10.1016\/j.bioorg.2025.108624_bb0045","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.vaccine.2024.01.100","article-title":"COVID-19 vaccines and adverse events of special interest: a multinational global vaccine data network (GVDN) cohort study of 99 million vaccinated individuals","volume":"42","author":"Faksova","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.bioorg.2025.108624_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16251","article-title":"Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review","volume":"31","author":"Mitsikostas","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bioorg.2025.108624_bb0055","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3390\/v15051171","article-title":"In silico and in vitro evaluation of some Amidine derivatives as hit compounds towards development of inhibitors against coronavirus diseases","volume":"15","author":"Hassan","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2025.108624_bb0060","doi-asserted-by":"crossref","first-page":"31339","DOI":"10.1039\/D1RA05817G","article-title":"Investigating the structure\u2013activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors","volume":"11","author":"El-Demerdash","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.108624_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130005","article-title":"5-((1H-imidazol-1-yl)methyl)quinolin-8-ol as potential antiviral SARS-CoV-2 candidate: synthesis, crystal structure, Hirshfeld surface analysis, DFT and molecular docking studies","volume":"1232","author":"Douche","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108624_bb0070","article-title":"A Mini-review on the common antiviral drug targets of coronavirus","volume":"12","author":"Wang","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.bioorg.2025.108624_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114225","article-title":"Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches","volume":"182","author":"Gioia","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108624_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.151","article-title":"The SARS-CoV-2 main protease (Mpro): structure, function, and emerging therapies for COVID-19","volume":"3","author":"Hu","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.bioorg.2025.108624_bb0085","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1021\/acs.jmedchem.4c02561","article-title":"Discovery of Nirmatrelvir (PF-07321332): a potent, orally active inhibitor of the severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) Main protease","volume":"68","author":"Tuttle","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108624_bb0090","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/acscentsci.3c00054","article-title":"SARS-CoV-2 Mpro protease variants of concern display altered viral substrate and cell host target Galectin-8 processing but retain sensitivity toward antivirals","volume":"9","author":"Chen","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.bioorg.2025.108624_bb0095","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1021\/acsptsci.5c00111","article-title":"Discovery of SARS-CoV-2 Nsp14-methyltransferase (MTase) inhibitors by harnessing scaffold-centric exploration of the ultra large chemical space","volume":"8","author":"Pal","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bioorg.2025.108624_bb0100","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41467-024-55421-5","article-title":"Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108624_bb0105","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-023-01392-w","article-title":"A new generation Mpro inhibitor with potent activity against SARS-CoV-2 omicron variants","volume":"8","author":"Huang","year":"2023","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.108624_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102667","article-title":"Structural biology of SARS-CoV-2 Mpro and drug discovery","volume":"82","author":"Duan","year":"2023","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bioorg.2025.108624_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115772","article-title":"Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: a comprehensive review","volume":"260","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108624_bb0120","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.chempr.2020.04.023","article-title":"Chemistry and biology of SARS-CoV-2","volume":"6","author":"D\u00f6mling","year":"2020","journal-title":"Chem"},{"key":"10.1016\/j.bioorg.2025.108624_bb0125","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.55730\/1300-0527.3460","article-title":"Synthesis, characterization, computational analyses, in silico ADMET studies, and inhibitory action against SARS-CoV-2 main protease (Mpro) of a Schiff base","volume":"46","author":"\u015eahin","year":"2022","journal-title":"Turk. J. Chem."},{"key":"10.1016\/j.bioorg.2025.108624_bb0130","first-page":"23522","article-title":"Regio- and diastereoselective synthesis of spiropyrroloquinoxaline grafted indole heterocyclic hybrids and evaluation of their anti-mycobacterium tuberculosis activity, RSC","volume":"10","author":"Arumugam","year":"2020","journal-title":"Advances"},{"key":"10.1016\/j.bioorg.2025.108624_bb0135","doi-asserted-by":"crossref","first-page":"15775","DOI":"10.1039\/D0RA01899F","article-title":"Anti-HIV drug repurposing against SARS-CoV-2","volume":"10","author":"Sang","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.108624_bb0140","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.jiph.2020.10.015","article-title":"Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: a molecular docking and drug repurposing approach","volume":"13","author":"Indu","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.bioorg.2025.108624_bb0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s42003-020-01577-x","article-title":"Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents","volume":"4","author":"Mody","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bioorg.2025.108624_bb0150","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1038\/s41467-020-16954-7","article-title":"Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography","volume":"11","author":"Kneller","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108624_bb0155","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1021\/jacsau.4c00508","article-title":"A structural comparison of Oral SARS-CoV-2 drug candidate Ibuzatrelvir complexed with the Main protease (Mpro) of SARS-CoV-2 and MERS-CoV","volume":"4","author":"Chen","year":"2024","journal-title":"JACS Au"},{"key":"10.1016\/j.bioorg.2025.108624_bb0160","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1021\/acs.jcim.3c01439","article-title":"Consensus pharmacophore strategy for identifying novel SARS-Cov-2 Mpro inhibitors from large chemical libraries","volume":"64","author":"Ruiz-Moreno","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2025.108624_bb0165","series-title":"The Practice of Medicinal Chemistry (Fourth Edition)","first-page":"243","article-title":"Chapter 9 - ring transformations","author":"Morice","year":"2008"},{"key":"10.1016\/j.bioorg.2025.108624_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140000","article-title":"Insights into the role of potent thiadiazole based Schiff base derivatives in targeting type-II diabetes: a combine in-vitro and in-silico approaches","volume":"1321","author":"Iqbal","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108624_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2023.104773","article-title":"Synthesis, in vitro thymidine phosphorylase inhibitory activity and molecular docking study of novel pyridine-derived bis-oxadiazole bearing bis-schiff base derivatives","volume":"16","author":"Hussain","year":"2023","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2025.108624_bb0180","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13065-024-01340-x","article-title":"Novel pyrrole based triazole moiety as therapeutic hybrid: synthesis, characterization and anti-Alzheimer potential with molecular mechanism of protein ligand profile","volume":"18","author":"Khan","year":"2024","journal-title":"BMC Chem."},{"key":"10.1016\/j.bioorg.2025.108624_bb0185","article-title":"Synthesis, characterization, DFT, AMDET and molecular docking reveals the binding mechanism of hydroxyl containing bis-schiff base derivatives: an approach toward alzheimer disease","volume":"10","author":"Arif","year":"2024","journal-title":"Res. Chem."},{"key":"10.1016\/j.bioorg.2025.108624_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138845","article-title":"Insight into role of triazole derived Schiff base bearing sulfonamide derivatives in targeting Alzheimer\u2019s disease: synthesis, characterization, in vitro and in silico assessment","volume":"1315","author":"Khan","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108624_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139995","article-title":"Biological study with molecular mechanism of imidazothiazole based Schiff bases as anti-Alzheimer agent: insight into the role of synthesis, molecular docking and ADMET analysis","volume":"1321","author":"Khan","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108624_bb0200","series-title":"Benzimidazole-Based Schiff Base Hybrid Scaffolds: A Promising Approach to Develop Multi-Target Drugs for Alzheimer\u2019s Disease, in: Pharmaceuticals","author":"Hussain","year":"2023"},{"key":"10.1016\/j.bioorg.2025.108624_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101540","article-title":"Identification of 1,2,4-triazole-bearing Bis-Schiff base hybrid scaffolds: in vitro and in silico insights to develop promising anti-urease and anti-cancer agents","volume":"7","author":"Khan","year":"2024","journal-title":"Results Chem."},{"key":"10.1016\/j.bioorg.2025.108624_bb0210","first-page":"335","article-title":"Synthesis, in vitro bio-evaluation and in silico molecular docking studies of Thiadiazole-based Schiff Base derivatives, future","volume":"16","author":"Khan","year":"2024","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108624_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135351","article-title":"Synthesis, in vitro bio-evaluation, and molecular docking study of thiosemicarbazone-based isatin\/bis-Schiff base hybrid analogues as effective cholinesterase inhibitors","volume":"1284","author":"Khan","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108624_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104798","article-title":"Stereoselective synthesis and discovery of novel spirooxindolopyrrolidine engrafted indandione heterocyclic hybrids as antimycobacterial agents","volume":"110","author":"Arumugam","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108624_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200121","article-title":"Thiazole-based SARS-CoV-2 protease (COV Mpro) inhibitors: design, synthesis, enzyme inhibition, and molecular modeling simulations","volume":"355","author":"Elsayed","year":"2022","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.108624_bb0230","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2025.108624_bb0235","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV","volume":"21","author":"Morse","year":"2020","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bioorg.2025.108624_bb0240","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0022-1759(94)90034-5","article-title":"A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia","volume":"174","author":"van de Loosdrecht","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2025.108624_bb0245","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1039\/D4MD00617H","article-title":"Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activity","volume":"16","author":"Buza","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108624_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107221","article-title":"Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: bioactivity, cytotoxicity, and molecular modeling studies","volume":"145","author":"G\u00fcle\u00e7","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108624_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.125558","article-title":"Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesterase","volume":"410","author":"G\u00fcle\u00e7","year":"2024","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2025.108624_bb0260","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108624_bb0265","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.drudis.2020.12.005","article-title":"Potential SARS-CoV-2 main protease inhibitors","volume":"26","author":"Banerjee","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.108624_bb0270","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108624_bb0275","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108624_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202100542","article-title":"Recent advances in the prediction of pharmacokinetics properties in drug design studies: a review","volume":"17","author":"Pantale\u00e3o","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.108624_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2023.107880","article-title":"Computational modeling of imines based anti-oxidant and anti-esterases compounds: synthesis, single crystal and in-vitro assessment","volume":"104","author":"Raza","year":"2023","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.108624_bb0290","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/cmdc.202000594","article-title":"Sulfonamide inhibitors of \u03b2-catenin signaling as anticancer agents with different output on c-MYC","volume":"15","author":"Di Magno","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.108624_bb0295","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2166037","article-title":"Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies","volume":"38","author":"Othman","year":"2023","journal-title":"J. Enz. Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108624_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135018","article-title":"Thiazole ring-cleavage: versatile products obtained in the course of synthesis of certain sulfonamide derivatives","volume":"1279","author":"Zeidan","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108624_bb0305","first-page":"5289","article-title":"Sulfonamides: synthesis and the recent applications in medicinal chemistry","volume":"63","author":"El-Gaby","year":"2020","journal-title":"Egypt. J. Chem."},{"key":"10.1016\/j.bioorg.2025.108624_bb0310","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ddr.21494","article-title":"Design and synthesis of simplified speciophylline analogues and \u03b2-carbolines as active molecules against plasmodium falciparum","volume":"80","author":"Pierrot","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2025.108624_bb0315","series-title":"Analysis of Cell Viability by the MTT Assay, Cold Spring Harbor Protocols, 2018","author":"Priti","year":"2018"},{"key":"10.1016\/j.bioorg.2025.108624_bb0320","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3390\/cancers11121927","article-title":"The anti-proliferative activity of the hybrid TMS-TMF-4f compound against human cervical Cancer involves apoptosis mediated by STAT3 inactivation","volume":"11","author":"Hong","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2025.108624_bb0325","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3390\/jcm9030704","article-title":"KCP10043F represses the proliferation of human non-small cell lung Cancer cells by caspase-mediated apoptosis via STAT3 inactivation","volume":"9","author":"Lee","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bioorg.2025.108624_bb0330","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.3390\/cancers13225849","article-title":"AKF-D52, a synthetic Phenoxypyrimidine-urea derivative, triggers extrinsic\/intrinsic apoptosis and cytoprotective autophagy in human non-small cell lung cancer cells","volume":"13","author":"Gil","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2025.108624_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122227","article-title":"Therapeutic role of 2-stearoxyphenethyl phosphocholine targeting microtubule dynamics and Wnt\/\u03b2-catenin\/EMT signaling in human colorectal cancer cells","volume":"334","author":"Park","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2025.108624_bb0340","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3390\/ph16111593","article-title":"Design, synthesis, in vitro, and in silico studies of new N5-substituted-pyrazolo[3,4-d]pyrimidinone derivatives as anticancer CDK2 inhibitors","volume":"16","author":"Zaki","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.108624_bb0345","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3390\/metabo13121202","article-title":"Tetraenone a: a new \u03b2-ionone derivative from Tetraena aegyptia","volume":"13","author":"Ashour","year":"2023","journal-title":"Metabolites"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:58:23Z","timestamp":1777463903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825005048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":69,"alternative-id":["S0045206825005048"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108624","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tipranavir analogs as antiviral agents: Design, synthesis, in vitro, and in silico study of new SARS-CoV-2 main protease inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108624","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108624"}}